Carson Wealth (CWM LLC)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$8.08M	Hold	216,565	–	–	0.06%	228
2021 Q1	$8.08M	Hold	216,565	–	–	0.06%	228
2020 Q4	$8.08M	Hold	216,565	–	–	0.06%	228
2020 Q3	$8.08M	Hold	216,565	–	–	0.06%	228
2020 Q2	$8.08M	Hold	216,565	–	–	0.06%	228
2020 Q1	$8.08M	Hold	216,565	–	–	0.06%	228
2019 Q4	$8.08M	Hold	216,565	–	–	0.06%	228
2019 Q3	$8.08M	Hold	216,565	–	–	0.06%	228
2019 Q2	$8.08M	Hold	216,565	–	–	0.06%	228
2019 Q1	$8.08M	Buy	+216,565	New	+$2.49M	0.06%	228

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Carson Wealth (CWM LLC)'s DRNA Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Dicerna Pharmaceuticals, Inc. (DRNA) position steady in Q2 2021 at 216,565 shares worth $8.08M. The position accounts for 0.06% of the portfolio, ranked #228.

Carson Wealth (CWM LLC) first reported a position in DRNA in Q1 2019 and has held it in 10 quarters since. 203 funds tracked by Wall St. Rank hold DRNA as of Q2 2021.

Carson Wealth (CWM LLC) held 216,565 shares of Dicerna Pharmaceuticals, Inc. worth $8.08M as of Q2 2021.
Carson Wealth (CWM LLC) left its Dicerna Pharmaceuticals, Inc. share count unchanged in Q2 2021.
Dicerna Pharmaceuticals, Inc. made up 0.06% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #228 holding.
Carson Wealth (CWM LLC) first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2019 and has held it in 10 quarters since.
203 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.